Its best used as part of a structured, medically guided wellness or weight loss program
Raloxifene belongs mainly in risk-reduction discussions for postmenopausal women
The caveat to follow the money is easily understandable when explained by a JP Morgan analyst who estimated that the global market for GLP-1 drugs will reach $71 billion by 2032, with Novo Nordisk (Ozempic) and Eli Lilly (Mounjaro) each accounting for 45% of the categorys sales
Lets break it down to understand what GLP-1 drugs are, how they work, and whether they might be a good option for someone with HS
Reports on GLP-1 use, nutrition, and obesity trends in India
You'll complete a brief medical intake, have your vitals checked, and review the recommended formula with our clinical team